275 related articles for article (PubMed ID: 8610236)
1. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer.
Edelstein MP; Wolfe LA; Duch DS
Semin Oncol; 1996 Apr; 23(2 Suppl 5):41-7. PubMed ID: 8610236
[TBL] [Abstract][Full Text] [Related]
2. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
4. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
Coltman CA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
[TBL] [Abstract][Full Text] [Related]
6. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
Crawford J
Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
[TBL] [Abstract][Full Text] [Related]
7. Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
Vokes EE; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J
Semin Oncol; 1994 Oct; 21(5 Suppl 10):35-8; discussion 38-41. PubMed ID: 7973767
[TBL] [Abstract][Full Text] [Related]
8. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.
Balcer-Kubiczek EK; Attarpour M; Edelman MJ
Cancer Chemother Pharmacol; 2007 May; 59(6):781-7. PubMed ID: 16957930
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells.
Fukuoka K; Arioka H; Iwamoto Y; Fukumoto H; Kurokawa H; Ishida T; Tomonari A; Suzuki T; Usuda J; Kanzawa F; Kimura H; Saijo N; Nishio K
Cancer Chemother Pharmacol; 2002 May; 49(5):385-90. PubMed ID: 11976832
[TBL] [Abstract][Full Text] [Related]
10. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
11. Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.
Burris HA; Fields S
Semin Oncol; 1994 Oct; 21(5 Suppl 10):14-9; discussion 19-20. PubMed ID: 7973764
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint.
Stuschke M; Sak A; Wurm R; Sinn B; Wolf G; Stüben G; Budach V
Int J Radiat Biol; 2002 Sep; 78(9):807-19. PubMed ID: 12428922
[TBL] [Abstract][Full Text] [Related]
13. Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.
Erjala K; Pulkkinen J; Kulmala J; Grénman R
Acta Oncol; 2004; 43(2):169-74. PubMed ID: 15163165
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
15. A summary of vinorelbine (Navelbine) safety data from North American clinical trials.
Hohneker JA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):42-6; discussion 46-7. PubMed ID: 7973769
[TBL] [Abstract][Full Text] [Related]
16. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
Brogden JM; Nevidjon B
Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
[TBL] [Abstract][Full Text] [Related]
17. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines.
Chen Y; Pandya K; Keng PC; Johnstone D; Li J; Lee YJ; Smudzin T; Okunieff P
Clin Cancer Res; 2003 Mar; 9(3):969-75. PubMed ID: 12631594
[TBL] [Abstract][Full Text] [Related]
19. Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: preliminary results.
Rathmann J; Leopold KA; Rigas JR
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):130-5. PubMed ID: 10210552
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.
Russell KJ; Wiens LW; Demers GW; Galloway DA; Plon SE; Groudine M
Cancer Res; 1995 Apr; 55(8):1639-42. PubMed ID: 7712467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]